Emerging research suggest this peptide, a dual stimulator targeting both GLP-1 and another hormone, may provide a significant step forward for body loss . Preliminary patient trials have indicated substantial reductions in body mass , potentially exceeding current body composition therapies . Despite this, further assessment is needed to completely